AP@home

| News

AP@home is an FP7 funded project and Triteq are one of twelve companies involved across Europe. The objective of AP@home is to build and evaluate an artificial pancreas (AP) with automated closed loop glycaemic control for insulin treated patients with diabetes.

AP systems require algorithms using blood glucose levels obtained via glucose monitoring for controlling subcutaneous insulin administration.

The project is in its second year and would like to announce the launch of their new AP@home Internet website. Please take a look at www.apathome.eu.

Leave a Reply

Your email address will not be published. Required fields are marked *

product design & development for:

Venturefest Oxford 2017

Over 500 delegates attended VentureFest Oxford 2017 this week, which was themed “From Start-Up to Scale-Up”. This excellent event brought together innovative start-ups, SME’s, investors and established Oxford success stories in a collaborative and learning environment. Angela Hobbs, Triteq’s Managing… more

Congratulations to Travis Wentworth for winning The Triteq Young Entrepreneur Award

Young Entrepreneur Award – The Triteq Young Entrepreneur Award recognises and celebrates the best young founder/s (under 40) of science and technology companies in the region, as demonstrated in the 2016–17 Venturefest Oxford pitching programme, which includes Pitchfest and Pitching… more

Life Science Innovation Showcase

This is your opportunity to engage with industry-leading figures at this exclusive exhibition, and network with specialists in attendance from across the Life Sciences eco-system.

View all events